Cardioprotective Effect of Semaglutide Are Independent of Adiposity and Weight
Posted2 months ago
thelancet.comResearchstory
calmpositive
Debate
0/100
SemaglutideCardiovascular HealthObesity Treatment
Key topics
Semaglutide
Cardiovascular Health
Obesity Treatment
A new study published in The Lancet found that semaglutide has a cardioprotective effect independent of weight loss, sparking interest in its potential benefits for cardiovascular health.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
N/A
Peak period
1
Start
Avg / period
1
Key moments
- 01Story posted
Oct 23, 2025 at 3:11 AM EDT
2 months ago
Step 01 - 02First comment
Oct 23, 2025 at 3:11 AM EDT
0s after posting
Step 02 - 03Peak activity
1 comments in Start
Hottest window of the conversation
Step 03 - 04Latest activity
Oct 23, 2025 at 3:11 AM EDT
2 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45679081Type: storyLast synced: 11/17/2025, 9:12:06 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
Interpretation The cardioprotective effects of semaglutide were independent of baseline adiposity and weight loss and had only a small association with waist circumference, suggesting some mechanisms for benefit beyond adiposity reduction.
(Funded by Novo nordisk)
Found via https://archive.is/URt7Y (the australian)